Revision as of 14:08, 7 August 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI').← Previous edit | Revision as of 14:19, 7 August 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or [[uNext edit → | ||
Line 1: | Line 1: | ||
{{drugbox | verifiedrevid = |
{{drugbox | verifiedrevid = 443510316 | ||
| | | | ||
| IUPAC_name = (6''R'',7''R'')-7-{amino}-3-methyl-8-oxo-5-thia-<br>1-azabicyclooct-2-ene-2-carboxylic acid | | IUPAC_name = (6''R'',7''R'')-7-{amino}-3-methyl-8-oxo-5-thia-<br>1-azabicyclooct-2-ene-2-carboxylic acid | ||
Line 20: | Line 20: | ||
| ChEMBL = 1604 | | ChEMBL = 1604 | ||
| ATC_suffix = DB09 | | ATC_suffix = DB09 | ||
| ChEBI_Ref = {{ebicite|correct|EBI}} | |||
| ChEBI = 3547 | | ChEBI = 3547 | ||
| PubChem = 38103 | | PubChem = 38103 | ||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = DB01333 | | DrugBank = DB01333 | ||
| KEGG_Ref = {{keggcite|correct|kegg}} | | KEGG_Ref = {{keggcite|correct|kegg}} |
Revision as of 14:19, 7 August 2011
Pharmaceutical compoundClinical data | |
---|---|
Routes of administration | Oral, IM, IV |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | Well absorbed |
Protein binding | <10% |
Metabolism | Nil |
Elimination half-life | 0.9 hours |
Excretion | Renal, unchanged |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.049.199 |
Chemical and physical data | |
Formula | C16H19N3O4S |
Molar mass | 349.406 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Cefradine (INN) (formerly cephradine BAN) is a first generation cephalosporin antibiotic.
Indications
It has similar spectrum of activity to cefalexin.
Formulations
Capsules containing 250 mg or 500 mg, Syrup containing 250 mg/5 ml, or vials for injection containing 500 mg or 1 g.
References
- British National Formulary 45 March 2003
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |